Ipamorelin

Buy Ipamorelin Online

Ipamorelin is a selective growth-hormone secretagogue peptide researched for growth hormone release, recovery, body composition, and metabolic research.

Product Information

Ipamorelin is a pentapeptide that activates the growth-hormone secretagogue receptor. Unlike some older GHRP compounds, research has shown relatively selective stimulation of GH without comparable stimulation of ACTH and cortisol.

How It Works

Ipamorelin mimics some of the signaling normally associated with ghrelin and activates the GHRP receptor, encouraging the pituitary to release growth hormone.

POTENTIAL BENEFITS

1. Growth Hormone Research

Ipamorelin strongly stimulates GH release in laboratory and animal models, making GH secretion one of its primary research applications.

2. Recovery Research

Because GH and IGF-1 pathways are involved in tissue maintenance and recovery, ipamorelin has attracted interest in research surrounding recovery and regenerative processes.

3. Body-Composition Research

Growth hormone signaling is closely connected with fat metabolism and lean-tissue maintenance, giving ipamorelin considerable interest in body-composition research.

4. Sleep & Recovery Research

GH secretion naturally follows a pulsatile pattern associated with sleep, which is one reason ipamorelin is frequently studied in relation to nighttime GH signaling.

5. Gastrointestinal Research

Ipamorelin has also been studied as a ghrelin-receptor agonist in postoperative gastrointestinal research.

Dosage

A human clinical trial investigated 0.03 mg/kg twice daily intravenously for postoperative ileus, but this was a specific hospital research protocol and not a general dosing regimen. Online peptide communities commonly discuss approximately 100–250 mcg per administration, with considerable variation.

Side Effects

Potential effects include headache, dizziness, injection-site reactions, increased appetite, and fluid retention associated with GH-pathway activity.

References

• Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PMID: 9849822.
• Bekker AY, et al. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus. Int J Colorectal Dis. PMID: 25331030.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to access instructions on how to make a payment.

How to Pay